These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15358300)

  • 21. Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer.
    Burger MT; Pecchi S; Wagman A; Ni ZJ; Knapp M; Hendrickson T; Atallah G; Pfister K; Zhang Y; Bartulis S; Frazier K; Ng S; Smith A; Verhagen J; Haznedar J; Huh K; Iwanowicz E; Xin X; Menezes D; Merritt H; Lee I; Wiesmann M; Kaufman S; Crawford K; Chin M; Bussiere D; Shoemaker K; Zaror I; Maira SM; Voliva CF
    ACS Med Chem Lett; 2011 Oct; 2(10):774-9. PubMed ID: 24900266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiazolidinedione-based PI3Kα inhibitors: an analysis of biochemical and virtual screening methods.
    Pinson JA; Schmidt-Kittler O; Zhu J; Jennings IG; Kinzler KW; Vogelstein B; Chalmers DK; Thompson PE
    ChemMedChem; 2011 Mar; 6(3):514-22. PubMed ID: 21360822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PI3Kα inhibitors that inhibit metastasis.
    Schmidt-Kittler O; Zhu J; Yang J; Liu G; Hendricks W; Lengauer C; Gabelli SB; Kinzler KW; Vogelstein B; Huso DL; Zhou S
    Oncotarget; 2010 Sep; 1(5):339-48. PubMed ID: 21179398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of dual inhibitors of the immune cell PI3Ks p110delta and p110gamma: a prototype for new anti-inflammatory drugs.
    Williams O; Houseman BT; Kunkel EJ; Aizenstein B; Hoffman R; Knight ZA; Shokat KM
    Chem Biol; 2010 Feb; 17(2):123-34. PubMed ID: 20189103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of phosphatidylinositol-3-kinase in cancer therapy.
    Ihle NT; Powis G
    Mol Aspects Med; 2010 Apr; 31(2):135-44. PubMed ID: 20176047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into the PI3-K-PKB-mTOR signalling pathway from small molecules.
    Gunn RM; Hailes HC
    J Chem Biol; 2008 Nov; 1(1-4):49-62. PubMed ID: 19568798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One hundred years of Meldrum's acid: advances in the synthesis of pyridine and pyrimidine derivatives.
    Lipson VV; Gorobets NY
    Mol Divers; 2009 Nov; 13(4):399-419. PubMed ID: 19381852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach.
    Niedermeier M; Hennessy BT; Knight ZA; Henneberg M; Hu J; Kurtova AV; Wierda WG; Keating MJ; Shokat KM; Burger JA
    Blood; 2009 May; 113(22):5549-57. PubMed ID: 19318683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory actions of the phosphatidylinositol 3-kinase inhibitor LY294002 on the human Kv1.5 channel.
    Wu J; Ding WG; Matsuura H; Tsuji K; Zang WJ; Horie M
    Br J Pharmacol; 2009 Jan; 156(2):377-87. PubMed ID: 19154427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy.
    Ihle NT; Powis G
    Mol Cancer Ther; 2009 Jan; 8(1):1-9. PubMed ID: 19139107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the phosphatidylinositol-3-kinase and extracellular regulated kinase pathways in the induction of hypoxia-inducible factor (HIF)-1 activity and the HIF-1 target vascular endothelial growth factor in ovarian granulosa cells in response to follicle-stimulating hormone.
    Alam H; Weck J; Maizels E; Park Y; Lee EJ; Ashcroft M; Hunzicker-Dunn M
    Endocrinology; 2009 Feb; 150(2):915-28. PubMed ID: 18845636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of the p110-alpha subunit of phosphatidylinositol-3-kinase is required for activation of epithelial sodium transport.
    Wang J; Knight ZA; Fiedler D; Williams O; Shokat KM; Pearce D
    Am J Physiol Renal Physiol; 2008 Sep; 295(3):F843-50. PubMed ID: 18653476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating PI3 kinase isoforms using Transcreener ADP assays.
    Klink TA; Kleman-Leyer KM; Kopp A; Westermeyer TA; Lowery RG
    J Biomol Screen; 2008 Jul; 13(6):476-85. PubMed ID: 18566477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein and lipid kinase inhibitors as targeted anticancer agents of the Ras/Raf/MEK and PI3K/PKB pathways.
    García-Echeverría C
    Purinergic Signal; 2009 Mar; 5(1):117-25. PubMed ID: 18523868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition.
    Torbett NE; Luna-Moran A; Knight ZA; Houk A; Moasser M; Weiss W; Shokat KM; Stokoe D
    Biochem J; 2008 Oct; 415(1):97-110. PubMed ID: 18498248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissecting isoform selectivity of PI3K inhibitors: the role of non-conserved residues in the catalytic pocket.
    Frazzetto M; Suphioglu C; Zhu J; Schmidt-Kittler O; Jennings IG; Cranmer SL; Jackson SP; Kinzler KW; Vogelstein B; Thompson PE
    Biochem J; 2008 Sep; 414(3):383-90. PubMed ID: 18489260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based design of an organoruthenium phosphatidyl-inositol-3-kinase inhibitor reveals a switch governing lipid kinase potency and selectivity.
    Xie P; Williams DS; Atilla-Gokcumen GE; Milk L; Xiao M; Smalley KS; Herlyn M; Meggers E; Marmorstein R
    ACS Chem Biol; 2008 May; 3(5):305-16. PubMed ID: 18484710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A membrane capture assay for lipid kinase activity.
    Knight ZA; Feldman ME; Balla A; Balla T; Shokat KM
    Nat Protoc; 2007; 2(10):2459-66. PubMed ID: 17947987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma.
    Fan QW; Cheng CK; Nicolaides TP; Hackett CS; Knight ZA; Shokat KM; Weiss WA
    Cancer Res; 2007 Sep; 67(17):7960-5. PubMed ID: 17804702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric oncology.
    Kurmasheva RT; Houghton PJ
    Curr Opin Chem Biol; 2007 Aug; 11(4):424-32. PubMed ID: 17652007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.